150 related articles for article (PubMed ID: 9365705)
1. Mycophenolate mofetil monotherapy significantly decreases the immune response of acute rejection in rat liver allografts.
Martelius T; Lautenschlager I; Mäkisalo H; Höckerstedt K
Transplant Proc; 1997 Nov; 29(7):3153-4. PubMed ID: 9365705
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.
Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P
Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil as induction therapy after liver transplantation.
McDiarmid SV
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
[No Abstract] [Full Text] [Related]
4. Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat.
Qi S; Chen H; Xu D; Daloze P
Transplant Proc; 1996 Apr; 28(2):932-3. PubMed ID: 8623468
[No Abstract] [Full Text] [Related]
5. Immunosuppression with cyclosporin A in combination with mycophenolate mofetil suppresses rejection of allogeneic fetal rat pancreatic allografts.
du Toit DF; Muller C; Page B; Mattysen J; Lyners R
Transplant Proc; 1998 Dec; 30(8):4092-3. PubMed ID: 9865308
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
Daly I; Jain A; Reyes J; Fung J
Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
[No Abstract] [Full Text] [Related]
7. Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443).
Räisänen-Sokolowski A; Aho P; Myllärniemi M; Kallio E; Häyry P
Transplant Proc; 1995 Feb; 27(1):435. PubMed ID: 7879051
[No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil rescue therapy in liver transplant recipients.
Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
[No Abstract] [Full Text] [Related]
9. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
[No Abstract] [Full Text] [Related]
11. HLA class I expression on peripheral blood lymphocytes and hepatocytes after liver transplantation.
Minguela A; Bermejo J; Pons JA; Miras M; Torio A; Marin L; García-Alonso AM; Ramírez P; Alvarez-López MR
Transplant Proc; 1999 Sep; 31(6):2466-8. PubMed ID: 10500673
[No Abstract] [Full Text] [Related]
12. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.
Fasola CG; Netto GJ; Jennings LW; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
Transplant Proc; 2002 Aug; 34(5):1563-4. PubMed ID: 12176486
[No Abstract] [Full Text] [Related]
13. A rat model of monitoring liver allograft rejection.
Martelius T; Mäkisalo H; Höckerstedt K; Taskinen E; Lautenschlager I
Transpl Int; 1997; 10(2):103-8. PubMed ID: 9089993
[TBL] [Abstract][Full Text] [Related]
14. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
Bahra M; Neumann UP; Harren M; Jacob D; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
[No Abstract] [Full Text] [Related]
15. Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat.
Valentin JF; Bruijn JA; Paul LC
Transplantation; 2000 Feb; 69(3):344-50. PubMed ID: 10706040
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
[No Abstract] [Full Text] [Related]
17. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
[No Abstract] [Full Text] [Related]
19. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
[No Abstract] [Full Text] [Related]
20. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
Gavlik A; Demirbas A; Tsaroucha A; Webb MG; Nery JR; Khan MF; Karatzas T; Khan RT; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
